Technology Application Identification

Your tech is going to change the world -- but how? DeciBio’s team of life scientists knows why and how your technology creates value, and we’ll help you find exactly where to focus to demonstrate that to customers and the broader market.

Our Experts

Miguel Edwards

Stephane Budel

Andrew Aijian

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

View

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

View

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Research Tools

Sequencing Technology Go-to-Market Strategy

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

View

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Pharma & Biotech

AI Patient Recruitment Go-to-Market Strategy

A healthcare technology startup wanted to conduct an assessment of potential go-to-market strategies for their AI analytical patient recruitment tool

View

Voice-of-Customer Research

Go-to-Market Strategy

Competitive Analysis

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

View

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch